OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway
Fan Wang, Chang Liu, Lingzhi Ren, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 427-436
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies
Bo Zhao, Xinrong Hu, Weidong Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 1

Structure-function relationship and biological activity of polysaccharides from mulberry leaves: A review
Yexian Hu, Yan Zhang, Xiaoao Cui, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 131701-131701
Closed Access | Times Cited: 7

Puerarin Attenuates Podocyte Damage in Mice With Diabetic Kidney Disease by Modulating the AMPK/Nrf2 Pathway
Song Xue, Wei Fan, Qingping Li, et al.
International Journal of Endocrinology (2025) Vol. 2025, Iss. 1
Open Access

Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications
Abhishek Satheesan, Janardanan Kumar, K.V. Leela, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2753-2779
Closed Access | Times Cited: 6

Bibliometric analysis of literature on natural medicines against chronic kidney disease from 2001 to 2024
Xiaoqing Shi, Hongmei Yin, Xiaodan Shi
Phytomedicine (2025), pp. 156410-156410
Closed Access

Molecular insights of diabetic nephropathy and chemical constituents-based treatment approach
Muhammed Amanat, Kanhaiya Lal, Thakur Gurjeet Singh, et al.
Phytochemistry Reviews (2025)
Closed Access

NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies
Aryan Rezaee, Parham Rahmanian, Amirreza Nemati, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29871-e29871
Open Access | Times Cited: 4

Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway
Jiabin Wu, Ke Li, Muge Zhou, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100946-100946
Open Access | Times Cited: 3

Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology
Zhi-yuan Guo, X. Wu, Shui-juan Zhang, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 3

Potential Role of Bmal1 in Lipopolysaccharide-Induced Depression-Like Behavior and its Associated "Inflammatory Storm"
Dandan Xu, Zhiqi Hou, Yayun Xu, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 2

Silencing LncRNA SNHG16 suppresses the diabetic inflammatory response by targeting the miR-212-3p/NF-κB signaling pathway
Linjuan Huang, Shengxi Xiong, Hanshuang Liu, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Imperatorin ameliorates kidney injury in diabetic mice by regulating the TGF-β/Smad2/3 signaling axis, epithelial-to-mesenchymal transition, and renal inflammation
Sourav Kundu, Ankana Ghosh, Karan Singh Yadav, et al.
European Journal of Pharmacology (2023) Vol. 963, pp. 176250-176250
Closed Access | Times Cited: 7

The intellectual base and global trends in inflammation of diabetic kidney disease: a bibliometric analysis
LuYao Shi, Chang‐Yan Li, Jian Wang, et al.
Renal Failure (2023) Vol. 45, Iss. 2
Open Access | Times Cited: 6

Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go
Jianxiu Yu, Xin Chen, Su-Gang Zang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1

Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury
Yufei Ye, Maoting Li, Wei Chen, et al.
Pharmacological Research (2024) Vol. 207, pp. 107301-107301
Open Access | Times Cited: 1

Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis
Xiaojun Li, Qiyuan Shan, X. Wu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1

Possible correlated signaling pathways with chronic urate nephropathy: A review
Kaiqing Li, Yanchun Ma, Xue Xia, et al.
Medicine (2023) Vol. 102, Iss. 32, pp. e34540-e34540
Open Access | Times Cited: 2

Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
Mohammad Sadra Gholami Chahkand, Yasaman Tavakoli, Ava Aghakhani, et al.
Turkish Journal of Immunology (2024), pp. 35-55
Open Access

Enteromorpha prolifera Polysaccharide Alleviates Acute Alcoholic Liver Injury in C57 BL/6 Mice through the Gut–Liver Axis and NF-κB Pathway
Tingting Yan, Jinghe Sun, Yuying Zhang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 42, pp. 23258-23270
Closed Access

Page 1 - Next Page

Scroll to top